Social and behavioral scientist with expertise in the implementation of evidence-based research to advance precision public health initiatives. She is a thought leader in the field of precision public health, with her work highlighted in Nature and Harvard Public Health Magazine. Her overarching research goal is to support the translation of genomics applications to maximize population health impact and improve health equity. To achieve this goal, Dr. Allen focuses on contributing to the field in three key areas: 1) participatory implementation science to support community engagement in genomics and precision public health research, 2) workforce diversity through the training of community health workers in genomics research competencies, and 3) novel approaches to communicating genomic information among diverse populations (e.g., risk communication, results disclosure, family health history). Dr. Allen is also a dedicated mentor who is passionate about training the next generation of scientists in the field of precision public health.

Assistant professor in the Division of Pharmaceutical Outcomes and Policy and the Director of Implementation Science in Precision Health and Society at the UNC Eshelman School of Pharmacy. Her research focuses on evaluating and improving the implementation of genomic medicine. In particular, she is interested in conducting research to understand how precision medicine technologies can be implemented to improve access to and reduce disparities in high-quality care and prevention. To date, her research has largely focused on the intersection between genomic medicine, health equity and implementation science including research about the implementation of population genetic screening, cascade screening for hereditary conditions, precision diagnostics in low resourced settings both globally and in the US, and building capacity for precision public health.

Dr. Baumann’s research agenda focuses on the intersection of implementation science, adaptation science, and healthcare equity. She works to identify strategies that facilitate the implementation of evidence-based interventions in low-resource settings and historically underserved populations, nationally and globally. In her national and global work, she has collaborated with several investigators in adapting and implementing evidence-based interventions in usual care, in different settings and with different disease areas. Specifically, to translational research, or the research that aims to turn observations from laboratories, clinics and communities into interventions and practices that improve the health of individuals and public, she has worked in the context of sickle cell, mental health and cancer.

Associate Professor of Medicine (Cardiology) and of Genetic Medicine and a certified genetic counselor (CGC) at the Johns Hopkins University School of Medicine. She is the Research Director of both the Johns Hopkins Center for Inherited Heart Diseases and the Johns Hopkins ARVC Precision Medicine Center of Excellence. Her research focuses on investigating the interplay of genotype and environmental factors on clinical outcomes in arrhythmogenic cardiomyopathies, defining the genetic architecture of inherited cardiomyopathies, and improving cardiovascular genetic counseling service delivery and outcomes. She is the PI of an NIH-funded 3-arm randomized clinical trial testing the impact of post-test focused genetic counseling models on patient empowerment, psychosocial, and medical outcomes as well as on genetic counseling efficiency and leads the international multicenter cardiovascular genetics outcome study. She also leads an international investigation of DSP-cardiomyopathy and has led development and refinement of a risk prediction model for incident sustained ventricular arrhythmias to support shared decision-making for ICD implantation in patients with ARVC. In these efforts, Dr. James enjoys collaborating with a multidisciplinary group of colleagues from the Johns Hopkins Departments of Medicine and Genetic Medicine, the Bloomberg School of Public Health and the Berman Institute of Bioethics as well as numerous cardiovascular genetics colleagues across the country and abroad.

Director of Feinberg’s Graduate Program in Genetic Counseling (GPGC). Prior to joining Northwestern, Duquette gained experience as a clinical genetic counselor, then served as state genomics coordinator for the Michigan Department of Public Health for 13 years. Duquette’s research interests include public health genomics, and genetic counseling and testing for oncology, cardiac and nephrology transplantation. Her research has been supported by the National Institutes of Health, American Heart Association, Patient-Centered Outcomes Research Institute and the Centers for Disease Control and Prevention. Most recently, the Warren Alpert Foundation joined this list of supporters, under the shared vision of propelling and fostering the career advancement of genetic counselors and genomics research.

Public health geneticist, Assistant Professor in the Genetics Department at the University of North Carolina at Chapel Hill, and Associate Director of the Program for Precision Medicine in Healthcare (PPMH) at the UNC School of Medicine. Her current research activities rely on evidence-based frameworks, community engagement, and mixed method approaches to work toward equitable clinical implementation of preventative population genetic screening. Dr. Milko is MPI of the Age-Based Genomic Screening (ABGS) R01 project, which is funded by the NIH to develop and evaluate a novel clinical program and implementation strategies to include highly actionable genetic information into pediatric well-child health care. She is the Executive Director of the UNC ClinGen U24 grant led by Jonathan Berg, and a member and co-chair of several ClinGen Working Groups, including the ClinGen Steering Committee. She is a co-Investigator on other NIH-supported research projects researching the implementation and dissemination of population genetic screening at UNC. She is also a Steering Committee member of the Newborn Screening Translational Research Network (NBSTRN) and a member of the NBSTRN Researcher Needs and Pilot Research and Implementation Workgroups and the CDC National Family Health History Working Group.

Assistant professor and founding program director of the Genetic Counseling Graduate Program. Her research interests include 1) assessing and improving appropriate access to cancer genetic risk assessment and testing services, 2) evaluating efficiency and outcomes of cancer genetic service deliver models, and 3) dissemination and implementation of evidence-based programs to prevent hereditary cancers.

Associate Professor of Medicine (Cardiology) and of Genetic Medicine and a certified genetic counselor (CGC) at the Johns Hopkins University School of Medicine. She is the Research Director of both the Johns Hopkins Center for Inherited Heart Diseases and the Johns Hopkins ARVC Precision Medicine Center of Excellence. Her research focuses on investigating the interplay of genotype and environmental factors on clinical outcomes in arrhythmogenic cardiomyopathies, defining the genetic architecture of inherited cardiomyopathies, and improving cardiovascular genetic counseling service delivery and outcomes. She is the PI of an NIH-funded 3-arm randomized clinical trial testing the impact of post-test focused genetic counseling models on patient empowerment, psychosocial, and medical outcomes as well as on genetic counseling efficiency and leads the international multicenter cardiovascular genetics outcome study. She also leads an international investigation of DSP-cardiomyopathy and has led development and refinement of a risk prediction model for incident sustained ventricular arrhythmias to support shared decision-making for ICD implantation in patients with ARVC. In these efforts, Dr. James enjoys collaborating with a multidisciplinary group of colleagues from the Johns Hopkins Departments of Medicine and Genetic Medicine, the Bloomberg School of Public Health and the Berman Institute of Bioethics as well as numerous cardiovascular genetics colleagues across the country and abroad.

Associate Professor at the University of Colorado. She graduated with her Doctor of Pharmacy from Purdue University and PhD in health information technology from the University of Colorado. She completed residency and a research fellowship at the Ohio State University and was a NHLBI K12 Implementation Science Scholar at the University of Colorado. She is a primary care clinical pharmacist and clinical informaticist at UCHealth and Chair of the Clinical Decision Support Working Group for the University of Colorado’s Center for Personalized Medicine’s Pharmacogenomics Implementation Committee Colorado (PICColo). Dr. Trinkley’s research focus is on advancing the visionary goals of learning health systems and leveraging data and implementation science to create innovative health information technologies to optimize safe and effective medication use. Much of her research focuses on clinical decision support tools within the electronic health record to optimize therapies for chronic cardiovascular disease.

Director of the Center for Interdisciplinary Research on Nicotine Addiction, a Professor in the Department of Psychiatry at the University of Pennsylvania, the Associate Director for Population Science and co-leader of the Tobacco and Environmental Carcinogenesis Program at the Abramson Cancer Center, and a Senior Fellow at Penn’s Center for Public Health Initiatives, where he teaches core courses for the Penn MPH program. Dr. Schnoll’s research focuses on the study of new methods for treating nicotine dependence, the examination of novel ways to use existing treatments for nicotine dependence to improve their efficacy, and the study of methods to improve the use of smoking cessation treatments, particularly in under-served or vulnerable populations. Dr. Schnoll has conducted behavioral, physician-based, and pharmacological clinical trials for smoking cessation, and conducted tobacco control research in India and Russia.

Assistant Professor at University of Washington in the Department of Health Systems and Population Health. Dr. Knerr’s research focuses on implementing guideline-recommended genomic tests, particularly to inform cancer prevention and control. She is also studying approaches to longitudinal care coordination for individuals with hereditary cancer syndromes with a focus on equity and sustainability. Dr. Knerr earned her M.P.H. from the Institute for Public Health Genetics and her Ph.D. in Health Services, both at the University of Washington.

Board-certified genetic counselor and social behavioral scientist. She is an associate professor at Emory School Public Health and the Co-director of the Emory Precision Public Health Research Program. Dr. Guan's research work has focused on promoting population health and eliminating health inequities through effective translation of evidence-based genomic-informed programs and policies. She has led or served as a co-investigator on projects related to: effective communication of genetic risk, implementation and dissemination of evidence-based genomic applications, and community engagement to expand the reach of genomic services to racial/ethnic minorities and rural communities.